Prodia Widyahusada Tbk PT Asset Resilience Ratio
Prodia Widyahusada Tbk PT asset resilience ratio. Prodia Widyahusada Tbk PT (PRDA) has an Asset Resilience Ratio of 7.82% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PRDA cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Prodia Widyahusada Tbk PT (2013–2024)
Asset resilience ratio of Prodia Widyahusada Tbk PT from 2013 to 2024. This chart shows how Prodia Widyahusada Tbk PT's Asset Resilience Ratio has changed over time. Read PRDA current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Prodia Widyahusada Tbk PT's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Prodia Widyahusada Tbk PT balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp82.60 Billion | 3.21% |
| Short-term Investments | Rp118.70 Billion | 4.61% |
| Total Liquid Assets | Rp201.30 Billion | 7.82% |
Asset Resilience Insights
- Limited Liquidity: Prodia Widyahusada Tbk PT maintains only 7.82% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Prodia Widyahusada Tbk PT Industry Peers by Asset Resilience Ratio
Compare Prodia Widyahusada Tbk PT's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
Diagnostics & Research | 0.16% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
Diagnostics & Research | 70.50% |
|
Krsnaa Diagnostics Limited
NSE:KRSNAA |
Diagnostics & Research | 9.90% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
Prodia Widyahusada Tbk PT Asset Resilience Ratio by Year (2013–2024)
Prodia Widyahusada Tbk PT asset resilience ratio by year from 2013 to 2024. The table below shows the annual Asset Resilience Ratio data for Prodia Widyahusada Tbk PT.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 17.15% | Rp487.02 Billion ≈ $28.54 Million |
Rp2.84 Trillion ≈ $166.42 Million |
-5.74pp |
| 2023-12-31 | 22.89% | Rp619.85 Billion ≈ $36.32 Million |
Rp2.71 Trillion ≈ $158.68 Million |
-3.33pp |
| 2022-12-31 | 26.22% | Rp699.95 Billion ≈ $41.01 Million |
Rp2.67 Trillion ≈ $156.43 Million |
-17.92pp |
| 2021-12-31 | 44.14% | Rp1.20 Trillion ≈ $70.31 Million |
Rp2.72 Trillion ≈ $159.30 Million |
+2.94pp |
| 2020-12-31 | 41.20% | Rp919.55 Billion ≈ $53.88 Million |
Rp2.23 Trillion ≈ $130.79 Million |
-9.12pp |
| 2019-12-31 | 50.32% | Rp1.01 Trillion ≈ $59.29 Million |
Rp2.01 Trillion ≈ $117.83 Million |
+1.75pp |
| 2018-12-31 | 48.56% | Rp937.48 Billion ≈ $54.93 Million |
Rp1.93 Trillion ≈ $113.11 Million |
-4.92pp |
| 2017-12-31 | 53.48% | Rp988.43 Billion ≈ $57.92 Million |
Rp1.85 Trillion ≈ $108.30 Million |
-11.51pp |
| 2016-12-31 | 64.99% | Rp1.19 Trillion ≈ $69.47 Million |
Rp1.82 Trillion ≈ $106.88 Million |
+64.11pp |
| 2015-12-31 | 0.88% | Rp5.10 Billion ≈ $298.72K |
Rp577.87 Billion ≈ $33.86 Million |
-0.02pp |
| 2014-12-31 | 0.90% | Rp5.70 Billion ≈ $334.14K |
Rp634.33 Billion ≈ $37.17 Million |
-0.38pp |
| 2013-12-31 | 1.28% | Rp6.56 Billion ≈ $384.22K |
Rp513.64 Billion ≈ $30.10 Million |
-- |
About Prodia Widyahusada Tbk PT
PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia specialty clinics; and offers vaccination, doctor consultation, and home services. It serves to individuals, doctors, and corporate and partnerships. The company was founded in 1973 and is headquartered in … Read more